# Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)

> **NCT05695378** · PHASE2 · TERMINATED · sponsor: **Kainos Medicine Inc.** · enrollment: 68 (actual)

## Conditions studied

- Multiple System Atrophy

## Interventions

- **DRUG:** KM-819
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05695378
- **Lead sponsor:** Kainos Medicine Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-27
- **Primary completion:** 2024-08-19
- **Final completion:** 2024-08-19
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** Sponsor has decided to withdraw the study due to safety issue and re-initiate with a new clinical study
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05695378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05695378, "Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05695378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*